Summary

Persistence Market Research has recently released a comprehensive report on the global pharmaceutical glass packaging market. The report provides an in-depth assessment of key market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the pharmaceutical glass packaging market from 2025 to 2032.

Key Insights:

• Pharmaceutical Glass Packaging Market Size (2025E): US$ 23.0 Billion
• Projected Market Value (2032F): US$ 44.3 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 9.8%

Pharmaceutical Glass Packaging Market - Report Scope:

Pharmaceutical glass packaging involves the production of glass containers used for storing and delivering pharmaceutical products, including vials, bottles, cartridges and syringes, and ampoules. These packaging solutions ensure product safety, maintain drug stability, and support sterile delivery systems for both generic and branded drugs, as well as biologics. The market caters to pharmaceutical manufacturers, contract packaging organizations, and healthcare providers worldwide. Market growth is driven by increasing demand for injectable drugs, biologics, and stringent regulatory requirements for high-quality and contaminant-free packaging.

Market Growth Drivers:

The global pharmaceutical glass packaging market is propelled by several key factors, including the rising adoption of injectable therapies and biologics across developed and emerging markets. Growing awareness of drug safety and the need for tamper-evident, high-quality packaging drives demand for Type I, II, and III glass packaging. Increasing pharmaceutical R&D investments, expanding biopharmaceutical pipelines, and the shift toward self-administration therapies are further boosting market growth. Additionally, the expansion of healthcare infrastructure in emerging economies supports the adoption of advanced glass packaging solutions.

Market Restraints:

Despite strong growth prospects, the pharmaceutical glass packaging market faces challenges related to high production costs and competition from alternative packaging materials such as plastics and polymer-based containers. Fragility, higher transportation costs, and environmental concerns related to energy-intensive glass manufacturing can restrain market expansion. Regulatory compliance requirements, including ISO standards for pharmaceutical glass, may also pose challenges for smaller manufacturers.

Market Opportunities:

The pharmaceutical glass packaging market presents significant opportunities driven by the growing biologics and biosimilars market. Increasing demand for prefilled syringes, cartridges, and advanced drug delivery systems creates new avenues for innovation in glass container designs. The rise in personalized medicine and home healthcare solutions further fuels demand for specialized packaging solutions. Strategic investments in sustainable glass manufacturing, lightweight containers, and digital serialization technologies offer additional growth potential.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the pharmaceutical glass packaging market globally?
• Which material types and product types are contributing most to market expansion?
• How are regulatory requirements and technological advancements shaping the competitive landscape?
• Who are the key players in the pharmaceutical glass packaging market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global pharmaceutical glass packaging market?

Competitive Intelligence and Business Strategy:

Leading players in the global pharmaceutical glass packaging market, including Amcor plc, AptarGroup, Inc., Becton, Dickinson, and Company, and Schott AG, focus on product innovation, high-quality manufacturing, and strategic partnerships to strengthen their market position. These companies invest in R&D to develop Type I, II, and III glass packaging that meets regulatory standards and enhances drug safety. Collaborations with pharmaceutical manufacturers and biotechnology firms enable faster adoption of next-generation packaging solutions. Sustainability initiatives and lightweight glass designs further enhance their competitive positioning in a dynamic market.

Key Companies Profiled:

• Amcor plc
• AptarGroup, Inc.
• Becton, Dickinson, and Company
• Schott AG
• Gerresheimer AG
• Drug Plastics Group
• West Pharmaceutical Services, Inc.
• SGD Pharma
• Owens Illinois, Inc.
• Berry Global, Inc.
• Vetter Pharma International
• CCL Industries, Inc.
• Comar, LLC
• International Paper
• WestRock Company
• Others

Pharmaceutical Glass Packaging Market Segmentation:

By Material Type:
• Type I
• Type II
• Type III

By Product Type:
• Vials
• Bottles
• Cartridges and Syringes
• Ampoules

By Drug Type:
• Generic
• Branded
• Biologic

By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Pharmaceutical Glass Packaging Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. COVID-19 Impact Analysis
2.4. Forecast Factors - Relevance and Impact
3. Value Chain Analysis
3.1. Supply Chain Analysis
3.2. List of Key Market Players
4. Value Added Insights
4.1. PESTLE Analysis
4.1.1. Porter’s Five Force Analysis
5. Price Trend Analysis, 2019 - 2032
5.1. Pricing Analysis, By Material
5.2. Key Factors Impacting Prices, By Product Type
6. Global Pharmaceutical Glass Packaging Market Outlook
6.1.
6.1.1. Market Size (US$ Bn) and Y-o-Y Growth
6.1.2. Absolute $ Opportunity
6.2. Market Size (US$ Bn) Analysis and Forecast
6.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
6.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
6.3. Global Pharmaceutical Glass Packaging Market Outlook: Material
6.3.1. Historical Market Size (US$ Bn) Analysis, By Material, 2019-2024
6.3.2. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
6.3.2.1. Type I
6.3.2.2. Type II
6.3.2.3. Type III
6.3.3. Market Attractiveness Analysis: Material
6.4. Global Pharmaceutical Glass Packaging Market Outlook: Product Type
6.4.1. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2024
6.4.2. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
6.4.2.1. Vials
6.4.2.2. Bottles
6.4.2.3. Cartridges and Syringes
6.4.2.4. Ampoules
6.4.3. Market Attractiveness Analysis: Product Type
6.5. Global Pharmaceutical Glass Packaging Market Outlook: Drug Type
6.5.1. Historical Market Size (US$ Bn) Analysis, By Drug Type, 2019-2024
6.5.2. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
6.5.2.1. Generic
6.5.2.2. Branded
6.5.2.3. Biologic
6.5.3. Market Attractiveness Analysis: Drug Type
7. Global Pharmaceutical Glass Packaging Market Outlook: Region
7.1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
7.2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
7.2.1. North America
7.2.2. Europe
7.2.3. East Asia
7.2.4. South Asia and Oceania
7.2.5. Latin America
7.2.6. Middle East & Africa
7.3. Market Attractiveness Analysis: Region
8. North America Pharmaceutical Glass Packaging Market Outlook
8.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.1.1. By Country
8.1.2. By Material
8.1.3. By Product Type
8.1.4. By Drug Type
8.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.2.1. U.S.
8.2.2. Canada
8.3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
8.3.1. Type I
8.3.2. Type II
8.3.3. Type III
8.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
8.4.1. Vials
8.4.2. Bottles
8.4.3. Cartridges and Syringes
8.4.4. Ampoules
8.5. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
8.5.1. Generic
8.5.2. Branded
8.5.3. Biologic
8.6. Market Attractiveness Analysis
9. Europe Pharmaceutical Glass Packaging Market Outlook
9.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.1.1. By Country
9.1.2. By Material
9.1.3. By Product Type
9.1.4. By Drug Type
9.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.2.1. Germany
9.2.2. France
9.2.3. U.K.
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Turkey
9.2.8. Rest of Europe
9.3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
9.3.1. Type I
9.3.2. Type II
9.3.3. Type III
9.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
9.4.1. Vials
9.4.2. Bottles
9.4.3. Cartridges and Syringes
9.4.4. Ampoules
9.5. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
9.5.1. Generic
9.5.2. Branded
9.5.3. Biologic
9.6. Market Attractiveness Analysis
10. East Asia Pharmaceutical Glass Packaging Market Outlook
10.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.1.1. By Country
10.1.2. By Material
10.1.3. By Product Type
10.1.4. By Drug Type
10.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
10.3.1. Type I
10.3.2. Type II
10.3.3. Type III
10.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
10.4.1. Vials
10.4.2. Bottles
10.4.3. Cartridges and Syringes
10.4.4. Ampoules
10.5. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
10.5.1. Generic
10.5.2. Branded
10.5.3. Biologic
10.6. Market Attractiveness Analysis
11. South Asia & Oceania Pharmaceutical Glass Packaging Market Outlook
11.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.1.1. By Country
11.1.2. By Material
11.1.3. By Product Type
11.1.4. By Drug Type
11.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.2.1. India
11.2.2. Southeast Asia
11.2.3. ANZ
11.2.4. Rest of South Asia & Oceania
11.3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
11.3.1. Type I
11.3.2. Type II
11.3.3. Type III
11.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
11.4.1. Vials
11.4.2. Bottles
11.4.3. Cartridges and Syringes
11.4.4. Ampoules
11.5. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
11.5.1. Generic
11.5.2. Branded
11.5.3. Biologic
11.6. Market Attractiveness Analysis
12. Latin America Pharmaceutical Glass Packaging Market Outlook
12.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
12.1.1. By Country
12.1.2. By Material
12.1.3. By Product Type
12.1.4. By Drug Type
12.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
12.2.1. Brazil
12.2.2. Mexico
12.2.3. Rest of Latin America
12.3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
12.3.1. Type I
12.3.2. Type II
12.3.3. Type III
12.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
12.4.1. Vials
12.4.2. Bottles
12.4.3. Cartridges and Syringes
12.4.4. Ampoules
12.5. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
12.5.1. Generic
12.5.2. Branded
12.5.3. Biologic
12.6. Market Attractiveness Analysis
13. Middle East & Africa Pharmaceutical Glass Packaging Market Outlook
13.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
13.1.1. By Country
13.1.2. By Material
13.1.3. By Product Type
13.1.4. By Drug Type
13.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
13.2.1. GCC Countries
13.2.2. Egypt
13.2.3. South Africa
13.2.4. Northern Africa
13.2.5. Rest of Middle East & Africa
13.3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
13.3.1. Type I
13.3.2. Type II
13.3.3. Type III
13.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
13.4.1. Vials
13.4.2. Bottles
13.4.3. Cartridges and Syringes
13.4.4. Ampoules
13.5. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025-2032
13.5.1. Generic
13.5.2. Branded
13.5.3. Biologic
13.6. Market Attractiveness Analysis
14. Competition Landscape
14.1. Market Share Analysis, 2025
14.2. Market Structure
14.2.1. Competition Intensity Mapping By Market
14.2.2. Competition Dashboard
14.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
14.3.1. Amcor plc
14.3.1.1. Overview
14.3.1.2. Segments and Material
14.3.1.3. Key Financials
14.3.1.4. Market Developments
14.3.1.5. Market Strategy
14.3.2. AptarGroup, Inc.
14.3.3. Becton, Dickinson, and Company
14.3.4. Schott AG
14.3.5. Gerresheimer AG
14.3.6. Drug Plastics Group
14.3.7. West Pharmaceutical Services, Inc.
14.3.8. SGD Pharma
14.3.9. Owens Illinois, Inc.
14.3.10. Berry Global, Inc.
14.3.11. Vetter Pharma International
14.3.12. CCL Industries, Inc.
14.3.13. Comar, LLC
14.3.14. International Paper
14.3.15. WestRock Company
14.3.16. Others
15. Appendix
15.1. Research Methodology
15.2. Research Assumptions
15.3. Acronyms and Abbreviations